iﬁc population of people with CLTI.
However, it was also felt that some of the recommendations of the CLTI guidelines should be adapted to the
speciﬁc population of people with diabetes. When it
was felt applicable, the guidelines of the American Diabetes Association (ADA), the European Association for
the Study of Diabetes (EASD) and other guidelines on peripheral artery disease (European Society of Cardiology
[ESC]-ESVS, European Society of Vascular Medicine
